Assessing peripheral neuropathy

Thursday 18th February 2021

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous about mentioning peripheral neuropathy, and often minimise its impact, as they are concerned that their treatment could be reduced or stopped.

GatewayC’s Managing Physical Effects course reviews the common side effects of cancer treatments and aims to help in the identification and management of some specific short- and long-term side effects, including peripheral neuropathy. This course features an interactive video consultation which demonstrates how a GP might assess the seriousness of the peripheral neuropathy of a colorectal cancer patient.

Find out more:

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Related Posts

The seasonal flu vaccine and cancer treatment

The seasonal flu vaccine and cancer treatment

Friday 6th November 2020 People living with cancer or undergoing cancer treatment are often immunosuppressed and at higher risk of catching the flu. After cancer treatment, a patient’s resistance to infection might be low for some months or years. It is recommended...

read more
Meet the specialists: lung cancer vs COVID-19 Q&A

Meet the specialists: lung cancer vs COVID-19 Q&A

Friday 30th October 2020 Missed our free GatewayC webinar on Lung Cancer vs COVID-19? Watch our recording here. In this webinar GatewayC met Dr Matthew Evison, Consultant Chest Physician and Director of the Lung Pathway Board, and Dr Seamus Grundy, Consultant...

read more